Call Us Sign-Up/Sign-In
Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market May See a Big Move | Aenova Group , Baxter BioPharma Solutions, Boehringer Ingelheim


iCrowdNewswire   Jan 11, 2021  8:57 AM ET

Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application, End User, and Region  , Covid 19 Outbreak Impact research report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market, and compares it with other markets., market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market size forecast, market data & Graphs and Statistics, Tables, Bar &Pie Charts, and many more for business intelligence. Get complete Report (Including Full TOC, 100+ Tables & Figures, and Chart). – In-depth Analysis Pre & Post COVID-19 Market Outbreak Impact Analysis & Situation by Region

Download Free Sample Copy of ‘Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market’ Report @

https://reportocean.com/industry-verticals/sample-request?report_id=GMD498

Key Segments Studied in the Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 

Global pharmaceutical CDMO market will reach $289.2 billion by 2030, growing by 6.9% annually over 2020-2030 driven by increasing demand for biological therapies and specialty medicines, rising demand for cost control in drug development, and rising healthcare expenditures.

Highlighted with 96 tables and 86 figures, this 194-page report “Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application, End User, and Region” is based on a comprehensive research of the entire global pharmaceutical CDMO market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

–           Market Structure

–           Growth Drivers

–           Restraints and Challenges

–           Emerging Product Trends & Market Opportunities

–           Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global pharmaceutical CDMO market in every aspect of the classification from perspectives of Category, Service Type, Therapeutic Application, End User, and Region.

Based on Category, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

–           Pharmaceutical Industry

–           Biopharmaceutical Industry

Based on Service Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Pharmaceutical Contract Manufacturing Organization (CMO)

–           Active Pharmaceutical Ingredients (API) (further split into Branded API Manufacturing and Generic API Manufacturing)

–           Finished Dosage Formulations (FDF) (further segmented into Solid Dosage, Oral Liquids, Parenteral/Injectables, Other FDFs)

–           Secondary Packaging

Pharmaceutical Contract Research Organization (CRO)

–           CRO for Pre-clinical Development

–           CRO for Phase I Trials

–           CRO for Phase II Trials

–           CRO for Phase III Trials

–           CRO for Phase IV Trials

–           Laboratory Services

–           Consulting Services

–           Data Management Services

Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

–           Infectious Diseases

–           Oncology

–           Metabolic Disorders

–           Cardiovascular Disorders

–           Central Nervous System

–           Pulmonary Disorders

–           Gastrointestinal Disorders

–           Other Therapeutic Applications

Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

–           Pharmaceutical & Biopharmaceutical Companies

–           Medical Device Companies

–           Academic Institutes

Geographically, the following regions together with the listed national/local markets are fully investigated:

–           APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

–           Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Turkey, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

–           North America (U.S., Canada, and Mexico)

–           South America (Brazil, Chile, Argentina, Rest of South America)

–           MEA (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Category, Service Type, and Therapeutic Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):

Company Profiles of CMO:

Aenova Group         

Baxter BioPharma Solutions       

Boehringer Ingelheim       

Catalent Inc.

Famar S.A.   

Hospira, Inc.

Jubilant Life Sciences Ltd.           

Lonza Group

Patheon Inc.

Pfizer CentreSource           

Recipharm AB         

Vetter Pharma International GmbH     

8.3.2 Company Profiles of CRO:

Charles River Laboratories          

CMIC Co. Ltd           

Covance Inc.

Hangzhou Tigermed Consulting Co Ltd

ICON Plc       

IQVIA Holdings Inc.          

LSK Global Pharma Service Co Ltd        

Novotech Pty Ltd    

PAREXEL International Corporation    

Pharmaceutical Product Development LLC (PPD)     

PRA Health Sciences Inc.  

Quanticate Ltd        

Samsung Bioepis Co. Ltd  

SGS SA (SGS Life Sciences)          

Syneos Health Inc. 

WuXi AppTec Inc.   

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Professional Key players: 

Key Players (this may not be a complete list and extra companies can be added upon request):

Company Profiles of CMO:

Aenova Group      

Baxter BioPharma Solutions 

Boehringer Ingelheim  

Catalent Inc.         

Famar S.A.

Hospira, Inc.

Jubilant Life Sciences Ltd.     

Lonza Group        

Patheon Inc.         

Pfizer CentreSource      

Recipharm AB     

Vetter Pharma International GmbH          

8.3.2 Company Profiles of CRO:

Charles River Laboratories    

CMIC Co. Ltd        

Covance Inc.         

Hangzhou Tigermed Consulting Co Ltd    

ICON Plc     

IQVIA Holdings Inc.     

LSK Global Pharma Service Co Ltd

Novotech Pty Ltd

PAREXEL International Corporation       

Pharmaceutical Product Development LLC (PPD)      

PRA Health Sciences Inc.       

Quanticate Ltd    

Samsung Bioepis Co. Ltd        

SGS SA (SGS Life Sciences)    

Syneos Health Inc.         

WuXi AppTec Inc.         

Market Segmentation:

Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application, End User, and Region

A combination of factors, including COVID-19 containment situation, end-use market recovery & Recovery Timeline of 2020/ 2021

covid-19 scenario

Market Behavior/ Level of Risk and Opportunity

End Industry Behavior/ Opportunity Assessment

Expected Industry Recovery Timeline

Business Impact Horizon

Opening of Economy by Q3 2020

xx

xx

xx

xx

Recovery – Opening of Economy extended till Q4 2020 / Q1 2021

xx

xx

xx

xx

Under COVID-19 Outbreak Impact Analysis:
We analyzed industry trends in the context of COVID-19. We analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets. We analyze the impact of COVID-19 on various regions and major countries.
The impact of COVID-19 on the future development of the industry is pointed out.

Study Explore :

For more information or any query mail at sales@reportocean.com

Geographical Breakdown: The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery path of Covid 19 for all regions, key developed countries and major emerging markets.

 

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

In-Depth Qualitative COVID 19 Outbreak Impact Analysis Include Identification And Investigation Of The Following Aspects: Market Structure, Growth Drivers, Restraints and Challenges, Emerging Product Trends & Market Opportunities, Porter’s Fiver Forces. The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios. The report basically gives information about the Market trends, growth factors, limitations, opportunities, challenges, future forecasts, and details about all the key market players.

(Check Our Exclusive Offer: 30% to 40% Discount)

https://reportocean.com/industry-verticals/sample-request?report_id=GMD498

Key questions answered: Study Explore COVID 19 Outbreak Impact Analysis

The study objectives of this report are:

The Study Explore COVID 19 Outbreak Impact Analysis

Inquire more and share questions if any before the purchase on this report at

https://reportocean.com/industry-verticals/sample-request?report_id=GMD498

Key Points Covered in Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Report:

Chapter 1, About Executive Summary to describe Definition, Specifications and Classification of Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market, Applications, Market Segment by Regions North America, Europe or Asia;
Chapter 2, objective of the study.
Chapter 3, to display Research methodology and techniques.
Chapter 4 and 5, to show the Overall Market Analysis, segmentation analysis, characteristics;
Chapter 6 and 7, to show the Market size, share and forecast; Five forces analysis (bargaining Power of buyers/suppliers), Threats to new entrants and market condition;
Chapter 8 and 9, to show analysis by regional segmentation, comparison, leading countries and opportunities; Regional Marketing Type Analysis, Supply Chain Analysis
Chapter 10, focus on identifying the key industry influencer’s, overview of decision framework accumulated through Industry experts and strategic decision makers;
Chapter 11 and 12, Market Trend Analysis, Drivers, Challenges by consumer behavior, Marketing Channels and demand & supply.
Chapter 13 and 14, describe about the vendor landscape (classification and Market Positioning)
Chapter 15, deals with Pharmaceutical Contract Development and Manufacturing Organization (CDMO)  Market sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

……..and view more in complete table of Contents

Browse Premium Research Report with Tables and Figures at @ https://reportocean.com/industry-verticals/sample-request?report_id=GMD498

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is “one-stop solution” for individuals, organizations, and industries that are looking for innovative market research reports.



Contact Information:

Get in Touch with Us:
Report Ocean
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 – UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)
Website: https://www.reportocean.com/
Blog: https://reportoceanblog.com/






Keywords:    Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market, Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Growth, Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Scope, Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Share, Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Trend, Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Development, Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Sales, Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast, Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Opportunities, Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size

Tags:    IPS, Reportedtimes, iCN Internal Distribution, Research Newswire, English